An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepixcompared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis
Summary
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-threatening fungal infection caused by several species of yeast called Candida.